Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0300556 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Roopa Hariprasad und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Indian Council Medical Research-National Institute of Epidemiology, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Acetic Acid, Early Detection of Cancer, Cost-Benefit Analysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Primary Human Papilloma Virus (HPV) testing offers higher sensitivity and specificity over Visual Inspection using Acetic acid (VIA) in cervical cancer screening. Self-sampling is a promising strategy to boost participation and reduce disparities. However, concerns about the initial costs hinder HPV testing adoption in low and middle-income countries. This study assesses the cost-utility of home-based HPV self-sampling versus VIA for cervical cancer screening in India.
Methods
A cross-sectional study was conducted in East district, Sikkim, India, comparing the costs and utility outcomes of population-based cervical cancer screening through VIA and primary HPV screening through self-sampling. Cost-related data were collected from April 2021 to March 2022 using the bottom-up micro-costing method, while utility measures were collected prospectively using the EuroQoL-5D-5L questionnaire. The utility values were converted into quality-adjusted life days (QALDs) for an 8-day period. The willingness to pay threshold (WTP) was based on per capita GDP for 2022. If the calculated Incremental Cost-Effectiveness Ratio (ICER) value is lower than the WTP threshold, it signifies that the intervention is cost-effective.
Results
The study included 95 women in each group of cervical cancer screening with VIA & HPV self-sampling. For eight days, the QALD was found to be 7.977 for the VIA group and 8.0 for the HPV group. The unit cost per woman screened by VIA and HPV self-testing was ₹1,597 (US$ 19.2) and ₹1,271(US$ 15.3), respectively. The ICER was ₹-14,459 (US$ -173.6), which was much below the WTP threshold for eight QALDs, i.e. ₹ 4,193 (US$ 50.4).
Conclusion
The findings support HPV self-sampling as a cost-effective alternative to VIA. This informs policymakers and healthcare providers for better resource allocation in cervical cancer screening in Sikkim.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Public Health, Indian Council Medical Research-National Institute of Epidemiology, Chennai, Tamil Nadu, India.
- Health Technology Assessment Resource Centre, Indian Council Medical Research-National Institute of Epidemiology, Chennai, Tamil Nadu, India.
- Department of Health and Welfare, Government of Sikkim, Gangtok, Sikkim, India.
- Jhpiego - an affiliate of Johns Hopkins University, Gangtok, Sikkim, India.
ORCID-Profile: Roopa Hariprasad, Bhavani Shankara Bagepally, Sajith Kumar, Deepsikka Gurung, Tarun Bhatnagar
Zitieren
APA
Hariprasad, R., Bagepally, B. S., Kumar, S., Pradhan, S., Gurung, D., Tamang, H., Sharma, A., & Bhatnagar, T. (2024). Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023. PLOS ONE. https://doi.org/10.1371/journal.pone.0300556
Vancouver
Hariprasad R, Bagepally BS, Kumar S, Pradhan S, Gurung D, Tamang H, et al. Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023. PLOS ONE. 2024. doi:10.1371/journal.pone.0300556
BibTeX
@article{Hariprasad2024,
author = {Hariprasad, Roopa and Bagepally, Bhavani Shankara and Kumar, Sajith and Pradhan, Sangeeta and Gurung, Deepsikka and Tamang, Harki and Sharma, Arpana and Bhatnagar, Tarun},
title = {Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0300556}
}
EUVIMED